Siemens Healthineers: maintains guidance, shares rise
(CercleFinance.com) - Shares in Siemens Healthineers have risen by over 4% in morning trading on Monday, after the German health technology company posted higher profit and revenue for its third quarter, which has led it to maintain its full-year earnings guidance.
The company, which sells products and services for diagnostic and molecular medicine to healthcare providers, said on Monday that its revenue rose by 8% to 3.6 billion euros for the three months to 30 June, compared to 3.3 billion euros a year earlier.
Comparable revenue growth reached 6% over the quarter, driven by sales of imaging and advanced therapies products, the group said.
Net income was 353 million euros, up 20% compared to the 293 million euros a year ago.
Siemens Healthineers confirmed its guidance for fiscal year 2019, still expecting comparable revenue growth to be in the range of 4% to 5% compared to fiscal year 2018.
It also stuck to its FY EPS growth target range of 20% to 30% relative to 2018.
Siemens Healthineers shares are currently up 4.4% at 37.3 euros in Frankfurt.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
The company, which sells products and services for diagnostic and molecular medicine to healthcare providers, said on Monday that its revenue rose by 8% to 3.6 billion euros for the three months to 30 June, compared to 3.3 billion euros a year earlier.
Comparable revenue growth reached 6% over the quarter, driven by sales of imaging and advanced therapies products, the group said.
Net income was 353 million euros, up 20% compared to the 293 million euros a year ago.
Siemens Healthineers confirmed its guidance for fiscal year 2019, still expecting comparable revenue growth to be in the range of 4% to 5% compared to fiscal year 2018.
It also stuck to its FY EPS growth target range of 20% to 30% relative to 2018.
Siemens Healthineers shares are currently up 4.4% at 37.3 euros in Frankfurt.
Copyright (c) 2019 CercleFinance.com. All rights reserved.